Seeing Is Believing
with an average price target of $-10.1. This is a potential upside of $-10.1 (0%) from yesterday's end of day stock price of $0.
Conatus Pharmaceuticals's activity chart (see below) currently has 12 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 208.5 days.
Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 22-Mar-2019. First documented stock forecast 22-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$8
$7.44 (1328.57%)
$8
5 years 8 months 4 days ago
(22-Mar-2019)
7/7 (100%)
$-4.8 (-37.50%)
216
Buy
$4
$3.44 (614.29%)
5 years 11 months 20 days ago
(06-Dec-2018)
1/1 (100%)
$-15.4 (-79.38%)
201
What is CNAT (Conatus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CNAT (Conatus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CNAT (Conatus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CNAT (Conatus Pharmaceuticals)?
Which analyst is the currently most bullish on CNAT (Conatus Pharmaceuticals)?
Which analyst is the currently most reserved on CNAT (Conatus Pharmaceuticals)?